Literature DB >> 15488949

C5 complement deficiency in a Spanish family. Molecular characterization of the double mutation responsible for the defect.

Eva Delgado-Cerviño1, Gumersindo Fontán, Margarita López-Trascasa.   

Abstract

The complement C5 deficiency is a recessive autosomal defect associated with recurrent infectious episodes, generally caused by Gram-negative micro-organisms. To date, only two mutations responsible for C5 deficiency have been characterized, both in heterozygosis. In this paper, we evaluate by immunochemical methods the C5 deficiency in a six-member family, in which one member suffered from meningococcal sepsis and several pneumonia episodes; and a second one with two bacterial meningitis episodes and frequent tonsillitis, pneumonia and herpetic episodes. We also characterize the molecular basis of this deficiency. No C5 protein was found in the serum from three of the children. They were found to be homozygous for a double mutation in the exon 40 of the C5 gene. The parents and the other children have half-normal levels of C5, and they were heterozygotes for the double mutation. This mutation modifies the reading frame, leading to a premature stop codon, and the resulting protein lacks 50 amino acids. As a result, homozygotes and heterozygotes have a total or a partial C5 deficiency respectively. This is the first report of a whole molecular characterization of C5 deficiency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15488949     DOI: 10.1016/j.molimm.2004.06.036

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

Review 1.  Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets.

Authors:  Pauline L Martin; Peter J Bugelski
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 2.  Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis.

Authors:  Marc Tebruegge; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

3.  Complement factor 5 (C5) p.A252T mutation is prevalent in, but not restricted to, sub-Saharan Africa: implications for the susceptibility to meningococcal disease.

Authors:  C Franco-Jarava; D Comas; A Orren; M Hernández-González; R Colobran
Journal:  Clin Exp Immunol       Date:  2017-04-20       Impact factor: 4.330

4.  Artificial surface-induced inflammation relies on complement factor 5: proof from a deficient person.

Authors:  Grethe Bergseth; John D Lambris; Tom Eirik Mollnes; Knut Tore Lappegård
Journal:  Ann Thorac Surg       Date:  2011-02       Impact factor: 4.330

Review 5.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

6.  Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature.

Authors:  Knut Tore Lappegård; Dorte Christiansen; Anne Pharo; Ebbe Billmann Thorgersen; Bernt Christian Hellerud; Julie Lindstad; Erik Waage Nielsen; Grethe Bergseth; Dag Fadnes; Tore G Abrahamsen; E Arne Høiby; Lone Schejbel; Peter Garred; John D Lambris; Morten Harboe; Tom Eirik Mollnes
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

Review 7.  C5 complement deficiency in a Saudi family, molecular characterization of mutation and literature review.

Authors:  Rand Arnaout; Sahar Al Shorbaghi; Hasan Al Dhekri; Hamoud Al-Mousa; Abdulaziz Al Ghonaium; Bandar Al Saud; Saleh Al Muhsen; Lina Al Baik; Abbas Hawwari
Journal:  J Clin Immunol       Date:  2013-02-01       Impact factor: 8.317

8.  Novel Mutations Causing C5 Deficiency in Three North-African Families.

Authors:  Roger Colobran; Clara Franco-Jarava; Andrea Martín-Nalda; Neus Baena; Elisabeth Gabau; Natàlia Padilla; Xavier de la Cruz; Ricardo Pujol-Borrell; David Comas; Pere Soler-Palacín; Manuel Hernández-González
Journal:  J Clin Immunol       Date:  2016-03-30       Impact factor: 8.317

9.  Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.

Authors:  F Corvillo; M Bravo García-Morato; P Nozal; S Garrido; A Tortajada; S Rodríguez de Córdoba; M López-Trascasa
Journal:  Clin Exp Immunol       Date:  2016-01-22       Impact factor: 4.330

10.  Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis.

Authors:  Anna M Blom; Fernando Corvillo; Michal Magda; Grzegorz Stasiłojć; Pilar Nozal; Miguel Ángel Pérez-Valdivia; Virginia Cabello-Chaves; Santiago Rodríguez de Córdoba; Margarita López-Trascasa; Marcin Okrój
Journal:  J Clin Immunol       Date:  2016-05-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.